{"id":"W4409255592","doi":"10.1182/blood.2024024476","title":"Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"National Comprehensive Cancer Network; Gilead Sciences; AstraZeneca; National Cancer Institute; National Institutes of Health; Pfizer","keywords":"Obinutuzumab; Chlorambucil; Medicine; Internal medicine; Chronic lymphocytic leukemia; Oncology; Leukemia; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000623467,0.0002234173,0.0005715891,0.0002636305,0.00003571603,0.0000202691,0.000338729,0.0001791815,0.00007356896],"category_scores_gemma":[0.0002407543,0.000150943,0.0001623191,0.0008277,0.0001489389,0.00005242565,0.00006740963,0.0002844617,0.00002222389],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.004713885,"about_ca_system_score_gemma":0.005902901,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004430044,"about_ca_topic_score_gemma":0.0006388999,"domain_scores_codex":[0.9980724,0.0001668627,0.000487908,0.0003595224,0.0004221899,0.0004911243],"domain_scores_gemma":[0.9986015,0.0004669623,0.00007978028,0.0007258291,0.0000786278,0.00004727515],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.04712302,0.02938547,0.2427358,0.003360962,0.005913268,0.002626232,0.04765188,0.00004008132,0.5138453,0.01657923,0.003511444,0.08722736],"study_design_scores_gemma":[0.5850374,0.003346937,0.1212417,0.000974833,0.0004699785,0.00008657113,0.005750346,0.001065296,0.2732377,0.001033464,0.007223819,0.0005319063],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989553,0.0009128732,0.000002648081,0.0005159709,0.0001392033,0.001003722,0.0000115165,0.00002536339,0.00783572],"genre_scores_gemma":[0.995971,0.0005574505,0.0000905253,0.0001755274,0.0000662848,0.0001196175,0.00002294268,0.00002618143,0.002970463],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5379144,"threshold_uncertainty_score":0.9997327,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01805478524415328,"score_gpt":0.3061912271200667,"score_spread":0.2881364418759135,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}